- Home
- PBYI vs EM Comparison
PBYI vs EM Comparison
Compare PBYI & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | EM |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 339.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PBYI | EM |
|---|---|---|
| Price | $5.92 | $1.21 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $7.00 | $1.25 |
| AVG Volume (30 Days) | 393.2K | ★ 922.3K |
| Earning Date | 11-06-2025 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.87 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | $211,995,000.00 | ★ $259,541,587.00 |
| Revenue This Year | N/A | $3.30 |
| Revenue Next Year | N/A | $5.26 |
| P/E Ratio | $7.94 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.58 | $0.68 |
| 52 Week High | $6.12 | $1.46 |
Technical Indicators
Market Signals| Indicator | PBYI | EM |
|---|---|---|
| Relative Strength Index (RSI) | 65.71 | 28.40 |
| Support Level | $5.51 | $1.18 |
| Resistance Level | $5.73 | $1.36 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 93.33 | 16.67 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.